|View printer-friendly version|
|Gilead Sciences’ Chief Scientific Officer John McHutchison Appointed Officer of the Order of Australia|
– Recognized for Services to
Dr. McHutchison is an internationally recognized leader in
gastroenterology and hepatology, with extensive expertise in clinical
and translational research in liver diseases. He joined Gilead in 2010,
and was appointed Chief Scientific Officer in
“I am deeply honored to receive this appointment,” said Dr. McHutchison. “I have been fortunate to work with many gifted and inspiring leaders in the liver disease field, and I am grateful to them for many years of collaboration, support and friendship.”
The Order of
“John is an inquisitive and insightful scientist who has helped to
transform the outlook for millions of people with liver disease around
the world,” said
Dr. McHutchison has undergraduate degrees in medicine and surgery from
This press release includes forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995 that are
subject to risks, uncertainties, and other factors. These risks,
uncertainties and other factors could cause actual results to differ
materially from those referred to in the forward-looking statements. The
reader is cautioned not to rely on these forward-looking statements.
These and other risks are described in detail in Gilead’s Quarterly
Report on Form 10-Q for the quarter ended
For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
Gilead Sciences, Inc.
Minimum 20 minute delay